Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Current Deferred Revenue (2020 - 2024)

Rani Therapeutics Holdings (RANI) has 2 years of Current Deferred Revenue data on record, last reported at $600000.0 in Q3 2024.

  • For Q3 2024, Current Deferred Revenue changed N/A year-over-year to $600000.0; the TTM value through Sep 2024 reached $600000.0, changed N/A, while the annual FY2020 figure was $2.7 million, N/A changed from the prior year.
  • Current Deferred Revenue reached $600000.0 in Q3 2024 per RANI's latest filing, down from $2.7 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $2.7 million in Q4 2020 and bottomed at $600000.0 in Q3 2024.